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Abstract 
Background: Evidence for optimal non-operative treatment of frozen shoulder is lacking. 
The aim of this study is to evaluate a treatment strategy for stage II-III Frozen shoulder 
provided by the current primary care Musculoskeletal Service. 
Methods: GP referrals of shoulder pain to the musculoskeletal service diagnosed with stage 
II-III frozen shoulder and who opted for a treatment strategy of hydrodistension and guided 
physiotherapy exercise programme over a 12 month period were evaluated for 6 months. 
Thirty three patients were diagnosed with stage II-III frozen shoulder by specialist 
physiotherapists and opted for the treatment strategy. Outcome measures included SPADI 
and QuickDASH, pain score and range of movement. Data was collected at baseline, 6 
weeks, 12 weeks and 6 months.   
Results: All patients significantly improved in shoulder symptoms on the SPADI and 
QuickDASH scores (p< 0.001). Pain scores and range of shoulder movement flexion, 
abduction, external rotation showed significant improvement at all time points (p<0.001).  
Conclusions: This service evaluation demonstrates that management of frozen shoulder 
stage II-III, by physiotherapists in a primary care setting utilizing hydrodistension and guided 
exercise programme is an effective non-operative treatment strategy.  
Level of evidence: Level III, Service evaluation. 
Keywords: Frozen shoulder; adhesive capsulitis; Hydrodistension; Primary Care; 
Physiotherapy; Cost; SPADI; QuickDASH. 
 
  
Background 
Frozen shoulder or adhesive capsulitis is a common clinical condition that presents to both 
primary and secondary care services. It has been extensively discussed and debated in the 
literature and is proposed to affect 8.2% of men and 10% of women of working age in the 
UK 1. The exact cause is unknown but is characterised by pain and progressive restriction of 
movement 2, 3. It is often classified into three stages stage I freezing (pain dominant), stage II 
frozen (pain & restriction), stage III thawing (restriction dominant) 4, 5. Debate regarding 
pathophysiology persists and ultimately contracture of the anterior capsule, coracohumeral 
and middle glenohumeral ligament occurs 3 6 7.  
The aim of treatment is to alleviate pain and restore shoulder movement. To meet this end, 
a number of treatment options are available including, medication, physiotherapy, 
corticosteroid injection, manipulation under anaesthetic (MUA), capsular release 
(arthroscopic and open) and hydrodistension. The efficiency of these interventions in 
relation to the frozen shoulder stage has yet to be established in clinical trials that would 
permit an evidence based pathway 8, 9.  
Hydrodistension was first described by Andren and Lundberg (1965)10 who described the 
injection into the glenohumeral joint under x-ray guidance. A Cochrane review 11 on the 
effectiveness and safety of hydrodistension based on five trials (n=196), involving only one 
of high quality12, found that the procedure may improve pain at 3 weeks and disability up to 
12 weeks. The authors concluded that there was evidence that distension with saline and 
steroid provided short term benefits in pain and range of movement in frozen shoulder. It is 
uncertain however as to whether it is better than alternative treatments.  
Hydrodistension is predominantly a secondary care procedure performed in radiology and 
estimated to cost up to £475.56 13. A recent health economic analysis found primary care 
hydrodistension cost £121.00 compared to £250.68 via radiology, producing a saving of 
£135.68 per patient when performed by a physiotherapist trained Sonographer14. Such cost 
benefits are enhanced when compared with MUA and capsular release which are estimated 
to cost £1446 and £2204 respectively13. Hydrodistension may therefore provide a treatment 
option for frozen shoulder patients which is relatively cheap, quick and if delivered in 
primary care easily accessible reducing the need to progress to surgery. This primary care 
delivered treatment could have a significant impact on health care costs, patient’s 
management and experiences. 
This service evaluation assessed the feasibility and effectiveness of an ultrasound guided 
hydrodistension and directed exercise programme for patients with frozen shoulder 
delivered by physiotherapists in a primary care setting. The study also considered the cost 
effectiveness of this procedure delivered in primary care with other published treatment 
costs.  
Method and Materials 
This one year prospective evaluation study was registered with the research & ethics 
department in line with our institutional policy, reference SE0456. Patients aged over 18 
years, diagnosed with frozen shoulder who received hydrodistension procedure and 
directed physiotherapy exercise programme as their treatment pathway between 
December 2014 and January 2016 were included. Hydrodistension was offered as a 
treatment option to all patients at time of diagnosis together with three other treatment 
options; physiotherapy exercise programme, standard intra-articular injection and guided 
physiotherapy exercise programme, or referral to secondary care for possible manipulation 
under anaesthesia (MUA) or shoulder capsular release. Patients who chose one of the other 
treatment pathways were excluded from the study. 
Diagnosis of frozen shoulder stage II-III was made following detailed history, clinical 
examination that demonstrating global movement restriction (both active and passive) 
particularly external rotation with or without pain and a normal glenohumeral joint x-ray, to 
exclude other pathology mimicking capsular restriction. This is consistent with previous 
studies diagnostic criteria 15 16, 17. Patients who opted for hydrodistension were counselled 
on the procedure and what to expect including their active role in the post procedure 
exercise programme. Consent was also sought from the patients for their outcome data to 
be used in this service evaluation at this point. 
Outcome measures 
Data was recorded prior to the hydrodistension procedure and at week 6, 12 weeks and 6 
months’ post procedure. The primary outcome measures were the Patient Reported 
Outcome Measures (PROMs), Disability Arm Shoulder Hand (QuickDASH) and Shoulder Pain 
Disability Index (SPADI) which have been shown to be valid and reliable tools to measure 
pain and disability in primary care settings with good construct validity for a variety of 
shoulder conditions including frozen shoulder,18,19, 20,21. The QuickDASH is an 18 question 
self-reported measure of the patients’ perceived difficulty to complete functional tasks 
using a numerical scale 1-5 then calculated to produce a score out of 100 points. The 
Minimal Clinically Important Difference (MCID) is the smallest change in score that patients’ 
perceive as a beneficial change in their condition giving rise to a change in the clinical 
management of the patient’s condition and is reported to be 14 for the QuickDASH 22.  
The SPADI is a self-reported questionnaire consisting of 13 items on two subscales: pain 5 
items and disability 8 items, using an 11-point numerical rating scale of difficulty 0-10. The 
scale produces a total score out of 130 and is subdivided into pain out of 50 and disability 
out of 80. The MCID for the SPADI is reported to be between 8-13 23. 
It is standard practice for all patients receiving treatment in the service to complete two 
Clinical Recorded Outcome Measures (CROMs): - (1) Pain score rated on a numerical scale 
from 0-10 (0=no pain, 10=severe pain), (2) Active shoulder movements of flexion, abduction 
and external rotation in degrees, measured using a goniometer. (Sammons Preston Roylan 
1-800-323-5547 #7514 30cm axis).  
Technique 
Following patient consent a routine ultrasound examination in sitting was performed to 
assess for a rotator cuff tear. The patient was then moved to the lateral decubitus for the 
guided hydrodistension.  
All injections were performed under image guidance using a GE Logic e Ultrasound Scanner 
(GE Healthcare UK) with a 6-12 MHz linear array transducer by the Consultant 
Physiotherapist MSK Sonographer. An aseptic no touch technique was used with sterile 
ultrasound gel following skin cleansing. The procedure was administered to the 
glenohumeral joint via the posterior approach. The posterior approach is often used with 
ultrasound to perform injections as it allows good needle and target visualisation 30 31 32.   
The patient was positioned in lateral decubitus position with the shoulder and elbow semi 
flexed resting on a pillow for comfort. Lidocaine 10 ml 1% was administered in real time as a 
hypoechoic volume within the glenohumeral joint, followed by 1 ml 40mg Triamcinolone 
Acetonide, finally 20ml 0.9% Sodium Chloride slowly to allow acceptance of the volume into 
the capsule. Rupture of the capsule can occur with this procedure and is felt as a sudden 
loss of resistance to injection, and visually on ultrasound the hypoechoic enlarged capsule 
deflates. Any adverse reactions that occurred during the procedure were recorded. 
Following the procedure passive stretching of the shoulder into external rotation, flexion 
and abduction was performed. Patients were then encouraged to exercise as much as 
possible with the stretching programme that had been given prior to this procedure. 
Patients were given a phone number and instructed to call the department after 10 days.  If 
they felt no improvement in movement or pain had been made a repeat procedure was 
undertaken. If there was improvement, patients were reviewed by a Specialist 
Physiotherapist at 6 weeks, 12 weeks and 6 months when data was collected as previously 
described.  
Statistical Analyses 
A repeated measures analysis of variance (RM-ANOVA) with pairwise comparison plus a 
Bonferroni correction was conducted at the pre-determined time points with an intention to 
treat analysis. Statistical analysis was performed using SPSS version 22.0 (SPSS Inc, Chicago, 
IL, USA).  
 
 
Results 
Table 1 shows the demographics of the patients. A total of 33 patients were included in the 
study.  Interestingly 12 patients had received previous unguided corticosteroid injections 
from various clinicians not the current service at various time points, which failed to 
improve symptoms, and 22 had previous received physiotherapy input by public and private 
physiotherapists. We did not differentiate the results of the 12 previously injected patients 
from the other patients who had not had previous injections because their outcome 
measures were no different. 
Table 1. Patient demographics 
 Mean Range Percentage 
Age 
 
54.5 (mean) 44-78  
Male 15    45% 
 
Female    18    55% 
 
Type II diabetic     8    24.2% 
 
Duration of 
symptom 
    8.6 3–20 months    - 
 
Previous injection  12  36.3% 
Previous 
Physiotherapy 
22  66.6% 
 
 
 
All 33 patients received hydrodistension and 2 patients received a repeat hydrodistension 
procedure at 2 weeks post the initial distension after the standard telephone consultation at 
ten days. The indication to repeat was poor improvement in pain and movement from initial 
procedure from the patient’s perspective and agreed on consultation with the clinician, no 
set improvement was quantified to be achieved following the first procedure. None of the 
repeat distension patients were diabetics.  Capsular rupture occurred in 3 patients but no 
alterations to treatment regimen were made and they followed standard post distension 
protocol.  All patients completed the data collection at the designated follow-up 
appointments. 
The RM-ANOVA shows significant differences (p<0.001) and a large effect size (ηp2>0.6) 
between the time point’s (see table 2). Pairwise comparisons with Bonferroni corrections 
show significant improvements between pre-treatment and 6 weeks, 3 months and 6 
months for Q-DASH, SPADI and Pain (p<0.001). No significant difference was seen between 
3 months and 6 months, however significant differences were seen between all other time 
points for Q-DASH (p=0.04 to p<0.001), SPADI (p<0.01) and Pain (p<0.01). In addition, 
significant improvements were seen between all-time points for range of motion in external 
rotation, abduction and flexion (p<0.001), (see table 3).   
Table 2. Mean and standard deviations  
 
Pre treatment 
mean (sd) 
 
6 weeks Post  
 mean (sd) 
  
3 Months 
post 
mean(sd) 
6 Months Post  
 mean (sd) 
RM 
ANOVA 
Partial Eta 
Squared (ηp2) 
Q-DASH 
 
46.1 (17.6) 17.8 (15.5) 11.3 (12.1) 8.2 (10.4) P<0.001 0.75 
SPADI 61.1 (21.3) 25.1 (23.2) 
 
14.9 (17.5) 
 
11.5 (15.5) 
 
P<0.001 0.74 
Pain 
VAS score 0-
10 
8.0 (1.1) 2.9 (2.3) 
 
1.9 (1.7) 
 
1.3 (1.4) 
 
P<0.001 0.84 
External 
rotation 
degrees 
7.3° (8.3) 31.8° (20.8) 
 
42.70 (18.7) 54.5° (27.5) P<0.001 0.66 
Abduction 
range 
degrees 
56.4° (19.4) 98.5° (39.1) 
 
123.50 (37.7) 
 
149.5° (36.5) 
 
P<0.001 0.76 
Flexion range 
degrees 
80.7° (18.9) 119.2° (36.2) 141.20 (27.2) 157.6° (23.5) P<0.001 0.76 
 
 
 
 
 
Table 3. Mean differences and Pairwise comparisons with Bonferroni correction 
 Q-DASH SPADI Pain ROM  
External 
rotation 
ROM  
Abduction 
ROM  
Flexion 
Pre to  
6 weeks 
28.2 35.9 5.1 -24.5 -42.1 38.5 
 (p<0.001) (p<0.001) (p<0.001) (p<0.001) (p<0.001) (p<0.001) 
Pre  
to 3 months 
 
34.7 
(p<0.001) 
46.1 
(p<0.001) 
6.1 
(p<0.001) 
-35.5 
(p<0.001) 
-67.1 
(p<0.001) 
-60.5 
(p<0.001) 
Pre  
to 6 months 
 
37.8 
(p<0.001) 
49.5 
(p<0.001) 
6.7 
(p<0.001) 
-47.3 
(p<0.001) 
-93.2 
(p<0.001) 
-76.8 
(p<0.001) 
6 weeks  
to 3 months 
 
6.5 
(p=0.042) 
10.2 
(p<0.01) 
1.0 
(p<0.01) 
-10.9 
(p<0.001) 
-25.0 
(p<0.001) 
-22.0 
(p<0.001) 
6 weeks  
to 6 months 
 
9.6 
(p<0.001) 
13.6 
(p<0.01) 
 
1.6 
(p<0.01) 
-22.7 
(p<0.001) 
-51.1 
(p<0.001) 
-38.3 
(p<0.001) 
3 months  
to 6 months 
 
3.1 
(p=0.16) 
3.4 
(p=0.73) 
0.6 
(p=0.13) 
-11.8 
(p<0.01) 
-26.1 
(p<0.001) 
-16.4 
(p<0.001) 
 
Discussion 
The patient demographics in this service evaluation are reflective of those previously 
reported in the literature 1. We concluded that all diagnoses of frozen shoulder were correct 
and there were no adverse incidents or complications in the evaluation. Although this is not 
a randomised controlled trial and only a small number of participants were studied, the 
results suggest ultrasound guided hydrodistension and physiotherapy guided exercise for 
patients with frozen shoulder stage II-III in a primary care setting is effective at improving 
pain, disability and movement. This improvement was maintained for 6 months for all 
outcome measures. In addition, no patients were unhappy with the outcome of treatment 
and none required onward referral to secondary care, and were happy to be discharged.  
Our results clearly demonstrated a large clinically significant change in the SPADI at all 3 
time points from baseline. Clinically an effective treatment should result in a significant 
change in the first 6 weeks; the MCID for the SPADI is reported to be an 8-13 point change 
23. We clearly surpassed the recommended level of change. Similarly, the MCID for the 
Quick DASH is reported to be a 14-point change 22; our Quick DASH results demonstrated a 
clinically significant sustained change at all 3 time points, (see table 2).   
Clinically recorded outcome measures of external rotation, abduction and flexion 
movements continued to show statistically significant improvements (p<0.001) and clinically 
important changes at all time points from baseline and between all-time points indicating a 
continued functional recovery of movement.  
The pain mean score significantly reduced from 8.0 (pre) to 2.9 (6 weeks) (p<0.001) showing 
a 64% reduction in pain after 6 weeks.  This reducing trend continued at 12 weeks to 1.9 
(p<0.001) giving a 77% reduction and also continued at 24 weeks reducing to 1.0 (p<0.001) 
giving an 84% reduction in pain all of which are significant (p<0.001). Pain was high on the 
priority list in a study exploring perceptions and priorities when living with primary frozen 
shoulder 24, and a main complaint in a recent paper looking at guided injection treatment 
for frozen shoulder 25.  Addressing the pain element as priority would reduce patient’s 
disability and improve their quality of life.  
These changes from baseline score were statistically significant and clinically important; 
however, there was no further change between time points. This indicates that the most 
significant improvements in patient reported outcomes occurred early in the treatment 
pathway after the hydrodistension procedure.  
Short term improvements in pain and function have been demonstrated in previous 
hydrodistension studies 12, 17. These short term improvements on pain and disability have 
also been documented with intra-articular cortisone injection 27, 28, 29 and enhanced if 
physiotherapy is used in conjunction with injection 13. A 2014 NHS study16 retrospectively 
investigating cortisone injection and physiotherapy for frozen shoulder provided in 
secondary care over a 12-month period highlighted statistically significant improvements in 
pain scores, but failed to document short or medium term pain outcomes, and failed to use 
a validated outcome measure. They report patients were seen on average for five 
appointments, this is the same as our study, however 22% (n=12) patients were referred for 
surgical opinion, unlike our study which referred none. This improvement could have 
occurred in the early or later stages of treatment but without the data collection stages 
being identified it is unclear at what time point this occurred. Our study demonstrates 
continued improvements at 6 weeks, 12 weeks and 6 months.  
We did not separate the results from the 12 patients that had previously received a 
cortisone injection because they all had clinical symptoms and were actively seeking 
treatment. Their outcomes did not differ from those who had not previously received a 
cortisone injection before entering the treatment pathway.  
Previous cost analysis has estimated costs of up to £475.56 for guided injection in secondary 
care and up to £2204 for surgical release 13. In comparison our treatment costs for frozen 
shoulder stage II-III in primary care are comparable with data published by O’Conaire (2012) 
hydrodistension, and Bateman et al (2014) non distension injection. This treatment 
approach offers significant saving to the NHS when comparing to secondary care guided 
injection and surgical costs at £475.56, £2204 13 respectively.  
Table 4.   Cost comparison with other published data. 
 Current 
service 
evaluation 
Hydrodistension 
Primary care 
O’ Conaire et al 
(2012) 
Secondary 
care guided 
injection 
Maund et al 
(2012) 
Surgery 
Maund et 
al (2012) 
 
Physio & 
injection 
Bateman et 
al (2014) 
 
Physio cost   
4 appts 
(£25.07hr) 
4 appts = 
1x40mins 
3x 20mins 
= £41.78 
Total staff cost 
 
=£121.00 
 
 
 
n/a 
 
 
n/a 
(£75.00hr) 
5 appts = 
2 hrs = 
=£135 
Consultant 
Physio cost x 
1 appt 
(£37.01hr) 
1x 30 min 
=£18.50 
  
n/a 
 
 
n/a 
 
 
n/a 
 
 
n/a 
Drugs & 
injection 
equipment 
=£10.00 included  
 
n/a 
 
n/a 
 
Included 
US 
equipment 
and facilities 
 
=£50.00 
 
£10 
 
n/a 
 
n/a 
 
Included 
Total  £120.28 £131.00 £299- 475  £2204 £135 
 
 
 
Conclusions 
The results of this small prospective service evaluation demonstrate ultrasound guided 
hydrodistension with guided exercise provided by physiotherapists in primary care is 
clinically effective for patients with frozen shoulder II-III. It also highlights the cost 
effectiveness of providing hydrodistension in a primary care setting and by doing so has 
potential significant financial benefit to the NHS if it is embedded in a national 
recommended treatment pathway for frozen shoulder.  
Whilst these findings do not provide new evidence on treatment efficacy they are in keeping 
with the previous findings of secondary care provided hydrodistension treatment. We have 
demonstrated that hydrodistension can be feasibly provided in a primary care setting by 
physiotherapists, easing the demand on secondary care services and potentially reducing 
the need for surgery for this condition. What is not clear is the efficacy of hydrodistension 
over non distension injection and guided physiotherapy.  
Further research should be conducted in the form of a randomised controlled trial to 
compare ultrasound guided hydrodistension with physiotherapy guided exercise, vs non 
distension ultrasound guided injection and physiotherapy guided exercise in the primary 
care setting. 
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